Relate the presence of type 2 diabetes mellitus as a risk factor in thyroid cancer ¿myth or reality? CMDLT- Caracas 2023

Authors

  • Alirio José Mijares Briñez Coordinador del programa de fellowship de cirugia de cabeza y cuello. Centro Medico Docente la Trinidad
  • Gabriela Marcano Antonucci Programa de fellowship de cirugia de cabeza y cuello. Centro Medico Docente la Trinidad
  • Carmen Maria Suarez Coordinadora del Programa de fellowship de cirugía gineco- oncologica. Centro Medico Docente la Trinidad
  • Diana Elisa Perez Ramirez Residente de postgrado asistencial de cirugia oncologica de cabeza y cuello. Centro medico docente la trinidad
  • Betania Cabrita Programa de fellowship de cirugia gineco - oncologica. Centro Medico Docente la Trinidad

DOI:

https://doi.org/10.55361/cmdlt.v17iSuplemento.384

Keywords:

Thyroid cancer, Type 2 diabetes mellitus, sitagliptin, metformin

Abstract

Objective: To establish the relationship between type 2 diabetes mellitus and the development of thyroid cancer in patients who attend the head and neck oncological surgery clinic of the CMDLT in the period between January 2018-January 2023. Methods: Type study observational, analytical, with case controls, cross-sectional, which included 24 patients, obtaining histopathological diagnosis of thyroid carcinoma and a previous history of diabetes. The epidemiological behavior and development of carcinoma in the presence of type 2 diabetes mellitus was evaluated. Result: More than half of the patients (61%) belonged to the group with both diagnoses, estimating a high probability between 26.6 and 50.8. % that a previous diagnosis of type 2 diabetes mellitus is a risk factor for developing thyroid cancer, with a CI of 95%. Furthermore, it is associated that the diagnosis of diabetes established more than 5 years may be responsible for the development of carcinogenesis; It was also confirmed that the most frequent histology was differentiated carcinoma, specifically papillary thyroid carcinoma (79%). Conclusion: The presence of diabetes mellitus as a risk factor is related to thyroid cancer in young patients, under 50 years of age, associated with a time greater than 5 years from the pathological endocrine diagnosis.

 

Published

2023-12-04

How to Cite

Mijares Briñez, A. J., Marcano Antonucci, G., Suarez, C. M., Perez Ramirez, D. E., & Cabrita, B. (2023). Relate the presence of type 2 diabetes mellitus as a risk factor in thyroid cancer ¿myth or reality? CMDLT- Caracas 2023. Revista Científica CMDLT, 17(Suplemento). https://doi.org/10.55361/cmdlt.v17iSuplemento.384

Issue

Section

Ciencias Quirúrgicas: Investigación